Cas:158930-09-7 Frovatriptan succinate manufacturer & supplier

Chemical Name:Frovatriptan succinate

CAS.NO:158930-09-7

Synonyms:Frovatriptan succinate anhydrous;UNII-36K05YF32G;Frovatriptan Succinate

Molecular Formula:C₁₈H₂₃N₃O₅

Molecular Weight:361.39200

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:515.2ºC at 760 mmHg

Density:N/A

Index of Refraction:

PSA:146.50000

Exact Mass:361.16400

LogP:2.55440

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Frovatriptan succinate anhydrous chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Frovatriptan Succinate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,UNII-36K05YF32G Use and application,Frovatriptan succinate anhydrous technical grade,usp/ep/jp grade.

Related News: Any drug or medication is composed of two components. Frovatriptan succinate manufacturer AstraZeneca Plc said on Monday that its cancer drug met the main goal of delaying the progression of a form of lung cancer. Frovatriptan succinate supplier Onconova is currently in the clinical development stage with oral and IV rigosertib, including clinical trials studying single agent IV rigosertib in second-line higher-risk MDS patients (pivotal Phase 3 INSPIRE trial) and oral rigosertib plus azacitidine in first-line and refractory higher-risk MDS patients (Phase 2). Frovatriptan succinate vendor Onconova is currently in the clinical development stage with oral and IV rigosertib, including clinical trials studying single agent IV rigosertib in second-line higher-risk MDS patients (pivotal Phase 3 INSPIRE trial) and oral rigosertib plus azacitidine in first-line and refractory higher-risk MDS patients (Phase 2). Frovatriptan succinate factory Any drug or medication is composed of two components.